Citigroup’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $293K | Sell |
29,528
-64,676
| -69% | -$642K | ﹤0.01% | 3181 |
|
|
2025
Q1 | $894K | Buy |
94,204
+295
| +0.3% | +$2.8K | ﹤0.01% | 2614 |
|
|
2024
Q4 | $1.3M | Buy |
93,909
+73,456
| +359% | +$1.01M | ﹤0.01% | 2425 |
|
|
2024
Q3 | $311K | Buy |
20,453
+9,190
| +82% | +$140K | ﹤0.01% | 3301 |
|
|
2024
Q2 | $53.7K | Sell |
11,263
-67,089
| -86% | -$320K | ﹤0.01% | 3807 |
|
|
2024
Q1 | $532K | Buy |
78,352
+54,554
| +229% | +$370K | ﹤0.01% | 2811 |
|
|
2023
Q4 | $116K | Sell |
23,798
-37,793
| -61% | -$185K | ﹤0.01% | 3401 |
|
|
2023
Q3 | $211K | Buy |
+61,591
| New | +$211K | ﹤0.01% | 2962 |
|
|
2022
Q2 | – | Sell |
-20
| Closed | – | – | 5409 |
|
|
2022
Q1 | $0 | Buy |
+20
| New | – | ﹤0.01% | 5463 |
|
|
2021
Q1 | – | Sell |
-900
| Closed | -$3K | – | 5496 |
|
|
2020
Q4 | $3K | Sell |
900
-200
| -18% | -$667 | ﹤0.01% | 5063 |
|
|
2020
Q3 | $6K | Hold |
1,100
| – | – | ﹤0.01% | 4541 |
|
|
2020
Q2 | $5K | Buy |
+1,100
| New | +$5K | ﹤0.01% | 4810 |
|